Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Neuro-Behcet's disease is a rare neurological complication of Behcet's disease presenting between second and fourth decades of life. The etiology of Behcet's disease is still unknown but genetic predisposition has been described to play a role. The disease is reported more in males than females. Neurological involvement could cause brain parenchymal, vascular or meningeal changes with other distinct systemic symptoms, which may include orogenital ulcers, uveitis and skin lesions. Parenchymal neuro-Behcet's disease has a poor prognosis. MRI aids in diagnosing and differentiating it from other entities. Treatment includes anti-inflammatory drugs and immunotherapeutics. Our case is the youngest adult reported so far and is an unusual presentation of neuro-Behcet's disease, as the patient was already in remission and on infliximab infusion. Key Words: Neuro-Behcet's, MRI, Infliximab.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.29271/jcpsp.2020.07.762 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Apremilast treatment of immune-mediated inflammatory skin diseases: a narrative review.
Front Pharmacol
August 2025
Department of Dermatology, Zhongshan Second People's Hospital, Zhongshan, Guangdong, China.
Novel therapeutic approaches on molecular pathways are being developed to treat inflammatory and autoimmune cutaneous dermatoses. Apremilast is an orally administered small-molecule phosphodiesterase 4 (PDE4) inhibitor that upregulates intracellular cyclic 3',5'-adenosine monophosphate (cAMP) levels to mediate a large array of proinflammatory cytokines as well as exerts its anti-inflammatory functions and therapeutic efficacy in skin diseases rather than an immunosuppressive mode of action. Early-phase clinical trials have demonstrated its favorable efficacy such that the United States Food and Drug Administration (USFDA) has approved its use for the treatment of psoriasis, psoriatic arthritis, and Behçet's syndrome.
View Article and Find Full Text PDFIntegrated stress response in Behçet disease: expression analyses in peripheral blood and synovial monocytes.
Rheumatol Int
September 2025
Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Fatih, 34093, Istanbul, Turkey.
Behçet disease (BD) is a chronic, relapsing inflammatory disorder, and human leukocyte antigen (HLA)-B*51 is considered to be the strongest genetic susceptibility factor. The integrated stress response (ISR), defined by the eIF2α/ATF4 axis, is a signaling network that maintains protein homeostasis and regulates innate immunity in eukaryotic cells; pathological activation of this pathway can affect the immune response and cause various diseases. In this study, we aimed to investigate the role of the ISR signaling pathway in the pathogenesis of BD.
View Article and Find Full Text PDFFunctional and taxonomic dysbiosis of the supragingival plaque metagenome in Behçet's disease.
J Oral Microbiol
August 2025
Department of Periodontology, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
Background: Behçet's Disease (BD), a complex autoinflammatory disorder, is increasingly linked to microbial dysbiosis, yet the specific microbial signatures and their functional consequences remain incompletely characterized. Elucidating these alterations is crucial for understanding BD pathogenesis.
Objective: To identify distinct microbial community structures and functional potentials in supragingival plaque microbiomes of BD patients versus healthy controls (HC) using high-resolution shotgun metagenomic sequencing.
Non-canonical manifestations of FMF in homozygous M694V MEFV genotype: Insights from a large patient cohort.
Semin Arthritis Rheum
August 2025
Rheumatology Unit, Sheba Medical Center, Tel Hashomer. Ramat Gan, 52621, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, P.O.B 39040. Ramat Aviv, Tel Aviv 69978, Israel; Department of Medicine F, Sheba Medical Center, Tel Hashomer. Ramat Gan, 52621, Israel. Electronic addre
Objectives: The homozygous M694V genotype is associated with the most severe form of familial Mediterranean fever (FMF). This study aims to explore whether this genotype is linked not only to classical FMF features, but also to additional, non-canonical manifestations.
Methods: A hypothesis-generating study was conducted using an automated algorithm to extract data from structured medical records of patients followed at the FMF clinic of Sheba Medical Center between 2010 and 2020.
[Infiltrative-ulcerative lesion of the larynx in Behcet's disease].
Vestn Otorinolaringol
September 2025
Sverzhevsky Research Clinical Institute of Otorhinolaryngology, Moscow, Russia.
The article describes a clinical case of differential diagnostic search for the cause of infiltrative ulcerative laryngitis in a young patient. Infectious, systemic, and neoplastic causes are excluded. Behcet's disease was diagnosed 11 years after the first clinical signs appeared.
View Article and Find Full Text PDF